TRADES
Latest Trades
78
results found for
ATAI
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 3 Apr 2023 Sell ATAI ATAI LIFE SCIENCES NV 119 0.0000
ARKG 31 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 430 0.0000
ARKG 30 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 5,110 0.0004
ARKG 29 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 79,263 0.0062
ARKG 28 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 1,273,310 0.0892
ARKG 23 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 48,358 0.0032
ARKG 21 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 14,047 0.0010
ARKG 10 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 29,565 0.0022
ARKG 9 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 7,535 0.0006
ARKG 8 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 13,389 0.0010
ARKG 7 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 151,880 0.0117
ARKG 6 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 110,939 0.0087
ARKG 3 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 269,962 0.0214
ARKG 2 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 121,517 0.0097
ARKG 1 Mar 2023 Sell ATAI ATAI LIFE SCIENCES NV 599 0.0001
ARKG 28 Feb 2023 Sell ATAI ATAI LIFE SCIENCES NV 162,680 0.0139
ARKG 27 Feb 2023 Sell ATAI ATAI LIFE SCIENCES NV 195,218 0.0165
ARKG 23 Feb 2023 Sell ATAI ATAI LIFE SCIENCES NV 42,209 0.0035
ARKG 27 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 66,383 0.0054
ARKG 26 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 17,205 0.0015
ARKG 25 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 48,924 0.0042
ARKG 24 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 127,894 0.0110
ARKG 23 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 209,730 0.0183
ARKG 20 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 24,926 0.0022
ARKG 19 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 28,079 0.0025
ARKG 18 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 396,692 0.0346
ARKG 17 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 318,588 0.0273
ARKG 13 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 41,270 0.0034
ARKG 12 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 892,197 0.0742
ARKG 11 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 82,677 0.0069
ARKG 10 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 739,145 0.0653
ARKG 9 Jan 2023 Sell ATAI ATAI LIFE SCIENCES NV 100,545 0.0094
ARKG 6 Sep 2022 Buy ATAI ATAI LIFE SCIENCES NV 769,176 0.1267
ARKG 2 Sep 2022 Buy ATAI ATAI LIFE SCIENCES NV 116,664 0.0193
ARKG 1 Sep 2022 Buy ATAI ATAI LIFE SCIENCES NV 171,857 0.0285
ARKG 31 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 25,264 0.0042
ARKG 30 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 162,997 0.0263
ARKG 29 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 39,607 0.0067
ARKG 26 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 156,519 0.0259
ARKG 25 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 44,026 0.0074
ARKG 24 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 135,114 0.0220
ARKG 23 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 60,967 0.0098
ARKG 22 Aug 2022 Buy ATAI ATAI LIFE SCIENCES NV 130,881 0.0205
ARKG 29 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 72,041 0.0099
ARKG 28 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 340,015 0.0451
ARKG 27 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 150,000 0.0201
ARKG 26 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 265,580 0.0338
ARKG 25 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 266,646 0.0342
ARKG 22 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 447,539 0.0573
ARKG 19 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 60,646 0.0093
ARKG 18 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 263,607 0.0385
ARKG 15 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 209,279 0.0305
ARKG 14 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 285,351 0.0407
ARKG 13 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 36,235 0.0051
ARKG 12 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 285,454 0.0416
ARKG 11 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 67,384 0.0096
ARKG 7 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 64,680 0.0095
ARKG 6 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 103,977 0.0145
ARKG 5 Jul 2022 Buy ATAI ATAI LIFE SCIENCES NV 100,317 0.0151
ARKG 14 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 208,584 0.0331
ARKG 11 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 61,840 0.0095
ARKG 10 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 30,700 0.0046
ARKG 9 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 1,030 0.0002
ARKG 7 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 85,260 0.0122
ARKG 4 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 149,437 0.0214
ARKG 3 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 227,370 0.0326
ARKG 2 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 65,329 0.0093
ARKG 1 Mar 2022 Buy ATAI ATAI LIFE SCIENCES NV 34,939 0.0052
ARKG 28 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 72,207 0.0106
ARKG 25 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 57,399 0.0085
ARKG 24 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 33,918 0.0052
ARKG 23 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 195,700 0.0295
ARKG 22 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 29,049 0.0044
ARKG 14 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 157,400 0.0227
ARKG 11 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 73,029 0.0102
ARKG 10 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 30,398 0.0042
ARKG 9 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 900 0.0001
ARKG 8 Feb 2022 Buy ATAI ATAI LIFE SCIENCES NV 83,278 0.0105
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.